Peptides stocked at glowaminos peptides
51 peptides currently tracked
Small-molecule NNMT inhibitor researched for fat cell metabolism, NAD+ salvage pathway regulation, and metabolic health.
Neuroprotective octapeptide from ADNP researched for microtubule stabilization and cognitive preservation.
Synthetic copper peptide researched for hair follicle stimulation, VEGF angiogenesis, and collagen production.
Synthetic analog of the growth-hormone 176–191 lipolytic region — developed by Metabolic Pharmaceuticals and the vers…
Synthetic 11-amino acid peptide derived from erythropoietin (EPO), researched for neuroprotection, tissue repair, and…
Synthetic 15-amino acid peptide derived from a gastric protein, researched for tissue repair, gut healing, tendon rec…
A cognitive research stack pairing Selank (an anxiolytic regulatory peptide) with Semax (a nootropic, neuroprotective…
Long-acting amylin receptor agonist developed by Novo Nordisk, researched for appetite regulation and weight manageme…
Novo Nordisk's fixed-dose combination of the amylin analog cagrilintide and the GLP-1 receptor agonist semaglutide — …
GH-secretagogue blend — CJC-1295 (no-DAC) and Ipamorelin, typically 5 mg each.
GHRH analog with a Drug Affinity Complex that extends half-life to 6-8 days, producing sustained GH elevation from a …
An angiotensin IV-derived peptidomimetic engineered for blood-brain-barrier penetration and oral activity, researched…
Nine-amino acid neuropeptide researched for sleep regulation, stress adaptation, and normalization of disturbed sleep…
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for telomerase activation, telomere elongation, and potential ant…
Copper-binding tripeptide researched for skin regeneration, wound healing, collagen stimulation, and anti-aging effects.
Three-peptide research blend — GHK-Cu, BPC-157 and TB-500; formula varies by vendor.
Modified insulin-like growth factor-1 with extended half-life (20+ hours). Researched for muscle growth, recovery, an…
Selective growth hormone secretagogue (GHS) that stimulates pulsatile GH release with minimal effects on cortisol and…
Four-peptide research blend — GHK-Cu, BPC-157, TB-500 and KPV in one vial.
Anti-inflammatory tripeptide from α-MSH researched for gut health, skin barrier repair, and NF-κB inhibition.
The only human cathelicidin antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi.
Dual GLP-1/glucagon receptor agonist developed by Innovent Biologics, in clinical trials for obesity and metabolic li…
Linear alpha-MSH analog (afamelanotide) approved in the EU as Scenesse® for erythropoietic protoporphyria. Researched…
Synthetic alpha-MSH analog researched for skin pigmentation (tanning), photoprotection, and sexual function enhancement.
A metabolic and longevity-oriented stack combining 5-Amino-1MQ, MOTS-c, and NAD⁺ — three compounds aimed at cellular …
Mitochondrial-derived peptide researched for metabolic regulation, exercise mimicry, insulin sensitivity, and longevity.
Nicotinamide adenine dinucleotide, a coenzyme essential for cellular energy metabolism, DNA repair, and sirtuin activ…
The first non-peptide oral small-molecule GLP-1 receptor agonist approved for chronic weight management — a once-dail…
A seven-amino-acid analog of the natural peptide spadin — a highly selective and potent blocker of the TREK-1 potassi…
PEGylated mechano growth factor — a modified IGF-1 splice variant with extended half-life, researched for muscle repa…
Bioregulatory tripeptide targeting the pineal gland, researched for neuroprotection, cognitive preservation, and mela…
Melanocortin receptor agonist (bremelanotide) FDA-approved as Vyleesi® for hypoactive sexual desire disorder in preme…
Synthetic heptapeptide derived from tuftsin, researched for anxiolytic effects, immune modulation, and cognitive enha…
GLP-1 receptor agonist for blood sugar regulation and weight management. Sold as Ozempic®, Wegovy®, and Rybelsus®.
Synthetic heptapeptide derived from ACTH(4-10), researched for neuroprotection, cognitive enhancement, and brain inju…
Synthetic 29-amino acid GHRH analog, the first FDA-approved GH-releasing peptide (Geref®). Stimulates natural pulsati…
Investigational small-molecule pan-ERR agonist (ERRα/β/γ) developed in the Burris laboratory, studied in animal model…
Synthetic octapeptide researched for reducing wrinkle depth by modulating SNARE complex formation, mimicking a topica…
Mitochondria-targeted tetrapeptide researched for restoring cellular energy production, reducing oxidative stress, an…
Dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim, in Phase 3 trials for obesity and MASH (metab…
Synthetic fragment of Thymosin Beta-4 researched for tissue repair, inflammation reduction, wound healing, and cardia…
Synthetic growth hormone-releasing hormone (GHRH) analog, FDA-approved as Egrifta® for HIV-associated lipodystrophy. …
GH-secretagogue blend — Tesamorelin (the only FDA-approved ingredient across these blends) and Ipamorelin, typically …
Investigational small-molecule triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally d…
Thymic peptide researched for immune modulation, T-cell activation, and antiviral response. Approved in over 35 count…
28-amino-acid neuropeptide researched for immune regulation, neuroprotection, and circadian rhythm modulation.
Two-peptide tissue-repair blend — BPC-157 and TB-500 in a 1:1 ratio.